A recent study explores the management of bullous pemphigoid and Norwegian scabies using a combination of dupilumab and ivermectin. This research could inform future treatment strategies for these rare skin conditions.
management of bullous pemphigoid and norwegian scabies with dupilumab plus ivermectin
Original title: “Management of Bullous Pemphigoid and Norwegian Scabies with Dupilumab Plus Ivermectin.”